GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93019C00011POP BIOTECHNOLOGIES INC

Overview

Award facts

Net obligations
$599.9K
$599,897of $599.9K potential value
Outlays (paid to date)
$48.16K
$48.16K paid of $599.9K obligated$48,161
Period of performance
Jun 17, 2019 to Apr 30, 2023
Ended
Modifications
5
Latest action Dec 27, 2022
Contract type
Definitive contract
PIID 75N93019C00011

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THE OBJECTIVE OF THIS CONTRACT IS TO UTILIZE A NEXT-GENERATION VACCINE ADJUVANT THAT INDUCES RAPID AND SERUM-STABLE SPONTANEOUS NANOLIPOSOME-ANTIGEN PARTICLEIZATION IN COMBINATION WITH MULTIPLE NATIVE FLEXIBLY LINKED (NFL) HIV ENVELOPE TRIMERS TO INDUCE HIGH LEVEL OF VIRUS-NEUTRALIZING ANTIBODIES FOLLOWING IMMUNIZATION.

Dates and value

Award date
Signed on Jun 13, 2019
Potential end of performance
Apr 29, 2023
Current value
$599,897Base and exercised options
Potential value (if all options are exercised)
$599,897

Obligations by fiscal year of action

  • FY2019: $599,897

Total across 1 fiscal year: $599,897

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 27, 2022. View on USAspending · Recipient on SAM.gov

Recipient

LocationBUFFALO, NY
UEIZWKMU75DGJY4
CAGE code7FCR8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Buffalo, Erie County, New York 14228-2710
Congressional district (place of performance)
NY-26As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
9

Solicitation and notices

Solicitation ID
SBIRPHS20191(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
A liposomal platform for spontaneous, particleized presentation of hiv trimer immunogens
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 13, 2019Base obligation at award: $599,897
Latest action
Dec 27, 2022 — Other administrative actionModification P00005; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action5
6 actions recorded, Jun 13, 2019 to Dec 27, 2022; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase i actionSR1

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2019/2019-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression